Among recipients with HIV, kidney transplantation from donors with HIV is noninferior to that from donors without HIV.

A multiomic analysis led by the IrsiCaixa AIDS Research Institute has uncovered genetic and immune mechanisms in some ...

Fostemsavir plus optimized background therapy was associated with improvements in immune biomarkers among HTE patients with MDR HIV infection.

Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly ...

The relatives of people who died after being given blood infected with HIV and hepatitis can now apply for interim ...

Progress has been made in HIV care. However, that doesn’t mean you don’t need a detailed plan for taking care of an ...

“With low uptake of PrEP among the communities most impacted by HIV, this insurance coverage requirement with ... The new ...

Researchers assessed whether switching to protease inhibitor-based antiretroviral therapy mitigates or reverses weight gain in patients with HIV infection.

The companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

Gilead Sciences, Inc. GILD and partner Merck MRK announced new results from a mid-stage study evaluating the investigational ...